• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fuji adds low-cost CR reader

Article

The low-end computed radiography market continues to grow as CR firms target low-volume applications for their technology. Fuji Medical Systems USA has become the latest company to enter this sector with the debut of FCR 5000RE, a CR system with a price

The low-end computed radiography market continues to grow as CR firms target low-volume applications for their technology. Fuji Medical Systems USA has become the latest company to enter this sector with the debut of FCR 5000RE, a CR system with a price of approximately $100,000. The release joins other low-cost offerings in the market, such as the ACR-2000 desktop CR reader from Sunnyvale, CA-based Lumisys, and ADC Solo from Agfa of Ridgefield Park, NJ.

FCR 5000RE features the same console as the company’s FCR 5000R reader, but does not include Fuji’s dynamic range control (DRC) image processing algorithms or HQ high-resolution mode. Fuji is targeting FCR 5000RE for low-volume remote clinics or ICU environments. A HIS/RIS interface is available as an option. Shipments will begin in July.

In other CR-related developments, Stamford, CT-based Fuji has debuted QA-WS771, a DICOM-compliant, Windows NT-based quality control workstation for technologists. QA-WS771 has a list price of $42,500.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.